A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

PHASE4TerminatedINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

October 14, 2021

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions
Pulmonary Arterial Hypertension
Interventions
OTHER

PAH Therapies

No Drug will be administered as part of this study. Real world data will be collected in participants who newly initiate PAH therapies in routine clinical setting or have already been receiving macitentan 10 mg for at least 3 months prior to the index date.

Trial Locations (54)

6591

The Catholic University of Korea Seoul St Mary s Hospital, Seoul

15213

University of Pittsburgh Medical Center, Pittsburgh

20123

Ospedale S.Giuseppe, Gruppo MultiMedica, Milan

21201

University of Maryland, Baltimore

21565

Gachon University Gil Medical Center, Incheon

27100

IRCCS Policlinico San Matteo, Università degli studi di Pavi, Pavia

28041

Hosp. Univ. 12 de Octubre, Madrid

28222

Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda

33511

Bay Area Cardiology Associates, P.A. - Brandon Office, Brandon

33606

University of South Florida, Tampa

39008

Hosp. Univ. Marques de Valdecilla, Santander

40202

Kentuckiana Pulmonary Associates, Louisville

45219

University of Cinncinnati Physicans- UC Health Physicnas Office, Cincinnati

49241

Pusan National University Hospital, Busan

50400

National Heart Institute, Kuala Lumpur

52242

University Of Iowa - Hospitals & Clinics, Iowa City

53127

Universitatsklinikum Bonn, Bonn

55905

Mayo Clinic - Rochester, Rochester

60611

Northwestern University, Chicago

65212

University of Missouri, Columbia

66160

University of Kansas Medical Center, Kansas City

87131

University of New Mexico, Albuquerque

100029

Beijing Anzhen Hospital, Beijing

100037

Beijing Fuwai Hospital, Beijing

100044

Peking Union Medical College Hospital, Beijing

169609

National Heart Centre (NHC) Singapore, Singapore

200433

Shanghai Pulmonary Hospital, Shanghai

610041

West China Hospital Sichuan University, Chengdu

02111-1526

Tufts Medical Center, Boston

48109-5000

University of Michigan, Ann Arbor

77030-1502

Houston Methodist Hospital, Houston

S2000DSR

Instituto Cardiovascular de Rosario, Rosario

30130-100

Universidade Federal De Minas Gerais - Hospital das Clínicas, Belo Horizonte

18618-970

Universidade Estadual Paulista 'Julio De Mesquita Filho', Botucatu

90020-090

Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre

05403 900

Hospital Das Clinicas Da Faculdade De Medicina Da USP, São Paulo

T6G 2R7

University of Alberta Hospital, Edmonton

N6A 5W9

London Health Sciences Centre Victoria Hospital, London

00161

Universita degli Studi di Roma 'La Sapienza' - Umberto I Policlinico di Roma, Rome

701-1192

National Hospital Organization Okayama Medical Center, Okayama

1081 HV

Vrije Universiteit Amsterdam (VU), Amsterdam

3430 EM

Sint Antonius Ziekenhuis, Nieuwegein

3015 CE

Erasmus MC, Rotterdam

31 202

Krakowski Szpital Specjalistyczny im Jana Pawla II, Krakow

20 718

Wojewodzki Szpital Specjalistyczny im Stefana Kardynala Wyszynskiego SPZOZ, Lublin

00928

CardioPulmonary Research, PSC, Guaynabo

03722

Severance Hospital Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

413 46

Sahlgrenska Universitetsjukhuset, Gothenburg

NW3 2QG

Royal Free Hospital, London

W12 0HS

Hammersmith Hospital, London

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

CB23 3RE

Papworth Hospital, Cambridge University, Papworth Everard

S10 2JF

Sheffield Teaching Hospitals NHS Foundation Trust Royal Hallamshire Hospital, Sheffield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY

NCT04955990 - A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants | Biotech Hunter | Biotech Hunter